Neurodegenerative Disease News and Research

RSS

Identification of 200 new proteins that interact with the mutated protein that causes Huntington's disease

The identification of more than 200 new proteins that interact with the mutated protein that causes Huntington's disease opens the door to developing treatments for the fatal neurodegenerative disorder, said a Baylor College of Medicine researcher who took part in the work that appears online today in the journal Public Library of Science Genetics.

11 May 2007

New compounds promising candidates for neurodegenerative disease drug development

Scientists have developed a novel strategy for tackling neurodegenerative diseases such as Huntington's disease: encouraging an individual's own cells to "eat" the malformed proteins that lead to the disease.

8 May 2007

Current approach to drug discovery for Lou Gehrig's disease be re-examined

Most research on Lou Gehrig's disease therapeutics has been based on the assumption that its two forms (sporadic and hereditary) are similar in their underlying cause.

8 May 2007

Avicena files composition of matter patent application for treatment of Huntington's disease

Avicena Group has announced day that it has filed a composition of matter patent application with the United States Patent and Trademark Office (USPTO) to cover potential treatments for Huntington's disease, a fatal neurodegenerative disease.

1 May 2007

Environment rich in sensory stimuli restores memory in mice with neurodegeneration

Mice whose brains had lost a large number of neurons due to neurodegeneration regained long-term memories and the ability to learn after their surroundings were enriched with toys and other sensory stimuli, according to new studies by Howard Hughes Medical Institute researchers.

30 Apr 2007

Avicena files composition of matter patent application for treatment of Parkinson's disease

Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.

27 Apr 2007

Moonlighting enzyme linked to Friedreich's ataxia

Friedreich's ataxia is one of those diseases few have heard of unless you know someone with the condition.

25 Apr 2007

Avicena files composition of matter patent application for treatment of Lou Gehrig's disease

Avicena Group has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office for Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease), a severe neurodegenerative disease.

24 Apr 2007

Embryonic stem cells provide new tool for studying disease and identifying ALS drugs

Results of two studies funded by Project A.L.S. and appearing in the advance online publication of Nature Neuroscience demonstrate that embryonic stem cells may provide a new tool for studying disease mechanisms and for identifying drugs to slow ALS, also known as Lou Gehrig's disease.

17 Apr 2007

Smoking and drinking lots of coffee may protect against Parkinson's disease

In what must be a rare example of smoking supposedly providing some benefit, researchers in the U.S. say in families with a history of Parkinson's disease, those who smoke cigarettes and drink lots of coffee appear to reduce their risk of developing the disease.

9 Apr 2007

Curry related compound shows promise against Kennedy's disease

Scientists who focus on the molecular signaling that underlies prostate cancer have discovered a compound that shows promise against a debilitating neurodegenerative condition known as Kennedy's disease, which is caused by a mutant gene.

21 Mar 2007

Pregnancy hormone prolactin gives hope to MS victims

Canadian scientists believe they may be some way to solving the mystery of why women suffering from multiple sclerosis (MS) go into remission while they are pregnant.

21 Feb 2007

Scientists find new genes linked to Lou Gehrig's disease

In the first genome-wide search for the genetic roots of the most common form of amyotrophic lateral sclerosis (ALS), Johns Hopkins scientists have newly identified 34 unique variations in the human genetic code among 276 unrelated subjects with ALS.

21 Feb 2007

Hormone prolactin key to repairing nerve cell damage

The mystery of why multiple sclerosis (MS) tends to go into remission while women are pregnant may be the secret to overcoming the devastating neurodegenerative disease, according to University of Calgary researchers who have shown that a pregnancy-related hormone is responsible for rebuilding the protective coating around nerve cells.

20 Feb 2007

Gene produces springy protein keeping nerve cells flexible

If you bend a knee or an elbow, the nerves in your limbs stretch but do not break. A University of Utah study suggests why: A gene produces a springy protein that keeps nerve cells flexible. When the gene was disabled in tiny nematode worms, their nerve cells literally broke.

29 Jan 2007

Yeast model system may provide a means for treating the earliest stage of Alzheimer's

A century ago this month, German psychiatrist Alois Alzheimer formally described characteristics of the neurodegenerative disease which ultimately came to bear his name. While international efforts to learn about Alzheimer's disease and develop treatments have progressed significantly in recent years, a cure remains an elusive goal.

19 Nov 2006

PGC-1 alpha implicated in Huntington's disease neurodegeneration

A metabolic disorder underlies the brain effects found in those with Huntington's disease, researchers report in an advance article publishing online October 19, 2006. The article will appear in the November 2006 issue of the journal Cell Metabolism, published by Cell Press.

20 Oct 2006

Neurodegenerative Disease News and Research

Identification of 200 new proteins that interact with the mutated protein that causes Huntington's disease

New compounds promising candidates for neurodegenerative disease drug development

Current approach to drug discovery for Lou Gehrig's disease be re-examined

Avicena files composition of matter patent application for treatment of Huntington's disease

Environment rich in sensory stimuli restores memory in mice with neurodegeneration

Avicena files composition of matter patent application for treatment of Parkinson's disease

Moonlighting enzyme linked to Friedreich's ataxia

Avicena files composition of matter patent application for treatment of Lou Gehrig's disease

Embryonic stem cells provide new tool for studying disease and identifying ALS drugs

Smoking and drinking lots of coffee may protect against Parkinson's disease

Curry related compound shows promise against Kennedy's disease

Pregnancy hormone prolactin gives hope to MS victims

Scientists find new genes linked to Lou Gehrig's disease

Hormone prolactin key to repairing nerve cell damage

Gene produces springy protein keeping nerve cells flexible

Yeast model system may provide a means for treating the earliest stage of Alzheimer's

PGC-1 alpha implicated in Huntington's disease neurodegeneration

Nicotine shows promise as treatment against Parkinson's disease

Promising therapy for Lou Gehrig's disease delivers antisense drug directly to nervous system

Scientists characterize structure of calbindin-D28K

Aneuro: A Year of Neuroscience in Review eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News